Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion type Assertion NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_head.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion description "[The following percentages of these genes were found to be aberrantly methylated in gastric cancer samples; TFPI2 (80.9%), GPX3 (30.1%), DMRT1 (46.9%), GPX1 (16.7%), IGFBP6 (22.6%) and IRF7 (32.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_provenance.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion evidence source_evidence_literature NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_provenance.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion SIO_000772 19195878 NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_provenance.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion wasDerivedFrom befree-20140225 NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_provenance.
- NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_assertion wasGeneratedBy ECO_0000203 NP672246.RASRe8aOjZ1fHzrwQa1yzr-fvIzZgH6IR0a_v0fCsVrvI130_provenance.